A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)

NCT06794541 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Intra-abdominal Infections (cIAI)

Interventions

DRUG: IV Eravacycline 2mg/kg
DRUG: IV Eravacycline 1.5mg/kg

Sponsor

Tetraphase Pharmaceuticals, Inc

Collaborators

[object Object]